278 Results for "

estrogen receptor (ER)

" in MedChemExpress (MCE) Product Catalog:
Products (278)

278 Results for "estrogen receptor (ER)" in MCE Product Catalog:

145
145 Publications Verification
Cat. No.: HY-13636
CAS No.: 129453-61-8
Purity:  99.92%
Synonyms: ICI 182780; ZD 9238; ZM 182780
Fulvestrant (ICI 182780) is a pure antiestrogen and a potent estrogen receptor (ER) antagonist with an IC50 of 9.4 nM. Fulvestrant is also a GPR30 agonist. Fulvestrant effectively inhibits the growth of ER-positive MCF-7 cells with an IC50 of 0.29 nM. Fulvestrant also induces autophagy and has antitumor efficacy .
loading...
    loading...
34
34 Cited Publications
Cat. No.: HY-103456
CAS No.: 805239-56-9
Purity:  99.70%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

PHTPP is a selective estrogen receptor β (ERβ) antagonist with 36-fold selectivity over ERα .
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-12870
CAS No.: 1639042-08-2
Purity:  99.28%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

AZD9496 is an effective, selective estrogen receptor (ERα) antagonist with an IC50 of 0.28 nM. AZD9496 is an orally active, selective estrogen receptor degrader (SERD).
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-12870A
CAS No.: 1639042-28-6
Purity:  99.35%
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

AZD9496 maleate is a potent and selective estrogen receptor (ERα) antagonist with IC50 of 0.28 nM. AZD9496 maleate is an orally bioavailable selective oestrogen receptor degrader (SERD).
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-19822
CAS No.: 722533-56-4
Synonyms: RAD1901
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Elacestrant (RAD1901) is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant also can inhibit growth of ER + breast cancer cell lines in vitro and in vivo .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-100689
CAS No.: 263717-53-9
Purity:  99.11%
Synonyms: PPT
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Propyl pyrazole triol (PPT) is a selective estrogen receptor alpha (ERα) agonist. The relative binding affinity of Propyl pyrazole triol for ERα (ERα: 49%) around 410 times higher compared with estrogen receptor beta (ERβ: 0.12%) .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-19822A
CAS No.: 1349723-93-8
Synonyms: RAD1901 dihydrochloride
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Elacestrant (RAD1901) dihydrochloride is an orally available and selective estrogen receptor degrader (SERD) with IC50s of 48 and 870 nM for ERα and ERβ, respectively. Elacestrant dihydrochloride also can inhibit growth of ER + breast cancer cell lines in vitro and in vivo .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-A0036
CAS No.: 198481-33-3
Synonyms: TSE-424 acetate
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Bazedoxifene acetate (TSE-424 acetate) is an oral, nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene acetate can be used for the research of osteoporosis. Bazedoxifene acetate also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer .
loading...
    loading...
19
19 Cited Publications
Cat. No.: HY-A0031
CAS No.: 198481-32-2
Synonyms: TSE-424
Target:  

Estrogen Receptor/ERR

Research Areas:  

Neurological Disease Cancer

Bazedoxifene (TSE-424) is an oral, BBB-penetrant nonsteroidal selective estrogen receptor modulator (SERM), with IC50s of 23 nM and 99 nM for ERα and ERβ, respectively. Bazedoxifene can be used for the research of osteoporosis. Bazedoxifene also acts as an inhibitor of IL-6/GP130 protein-protein interactions and can be used for the research of pancreatic cancer .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-12452
CAS No.: 1428-67-7
Purity:  99.66%
Synonyms: Diarylpropionitrile
DPN (Diarylpropionitrile) is a non-steroidal estrogen receptor β (ERβ) selective ligand, with an EC50 of 0.85 nM. DPN has neuroprotective effects in a number of neurological diseases .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-103454B
CAS No.: 2863676-89-3
Purity:  99.28%
Research Areas:  

Endocrinology Cancer

MPP hydrochloride is a potent and selective ER (estrogen receptor) modulator. MPP hydrochloride induces significant apoptosis in the endometrial cancer and oLE cell lines. MPP hydrochloride reverses the the positive effects of beta-estradiol. MPP hydrochloride has mixed agonist/antagonist action on murine uterine ERalpha in vivo .
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-103454
CAS No.: 911295-24-4
Purity:  99.54%
Research Areas:  

Endocrinology Cancer

MPP dihydrochloride is a potent and selective ER (estrogen receptor) modulator. MPP dihydrochloride induces significant apoptosis in the endometrial cancer and oLE cell lines. MPP dihydrochloride reverses the positive effects of beta-estradiol. MPP dihydrochloride has mixed agonist/antagonist action on murine uterine ERalpha in vivo .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-N0377
CAS No.: 578-86-9
Synonyms: 4',7-Dihydroxyflavanone
Liquiritigenin, a flavanone isolated from Glycyrrhiza uralensis, is a highly selective estrogen receptor β (ERβ) agonist with an EC50 of 36.5 nM for activation of the ERE tk-Luc.
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-N0233
CAS No.: 19879-32-4
Synonyms: Corylifolin
Bavachin, a flavonoid first isolated from seeds of P. corylifolia, acts as a phytoestrogen that activates the estrogen receptors ERα and ERβ with EC50s of 320 and 680 nM, respectively.
loading...
    loading...
11
11 Cited Publications
Cat. No.: HY-10426
CAS No.: 725247-18-7
Purity:  99.67%
Research Areas:  

Cancer

XCT-790 is a potent and selective inverse agonist for ERRα with an IC50 value of 0.37 μM. XCT-790 induces cell death in chemotherapeutic resistant cancer cells. XCT-790 (Compound 12) is inactive against ERRγ and the estrogen receptors ERα and ERβ .
loading...
    loading...
9
9 Cited Publications
Cat. No.: HY-138642
CAS No.: 2229711-68-4
Purity:  99.60%
Synonyms: ARV-471; PF-07850327
Research Areas:  

Cancer

Vepdegestrant (ARV-471) is an orally active PROTAC estrogen receptor degrader against breast cancer. Vepdegestrant is a hetero-bifunctional molecule that facilitates the interactions between estrogen receptor alpha and an intracellular E3 ligase complex. Vepdegestrant leads to the ubiquitylation and subsequent degradation of estrogen receptors via the proteasome. Vepdegestrant robustly degrades ER in ER-positive breast cancer cell lines with a half-maximal degradation concentration (DC50) of about 2 nM .
loading...
    loading...
8
8 Cited Publications
Cat. No.: HY-136255
CAS No.: 2222844-89-3
Purity:  99.32%
Synonyms: AZD-9833
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

Camizestrant (AZD-9833) is a potent and orally active estrogen receptor (ER) antagonist. Camizestrant is used for the study of ER + HER2-advanced breast cancer .
loading...
    loading...
7
7 Cited Publications
Cat. No.: HY-B0412
CAS No.: 50-27-1
Synonyms: Oestriol
Estriol (Oestriol), an orally active estrogen, is a ERα and ERβ agonist. Estriol is a potent GPR30 antagonist in estrogen receptor-negative breast cancer cells. Estriol can ameliorate disease severity through immunomodulatory mechanisms that decrease tissue inflammation. Estriol has powerful proconvulsant effects .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-109176
CAS No.: 1953133-47-5
Purity:  99.52%
Synonyms: GDC-9545; RG6171
Target:  

Estrogen Receptor/ERR

Research Areas:  

Endocrinology Cancer

Giredestrant (GDC-9545) is an orally active, full, selective Estrogen receptor α (ERα) degrader and antagonist with a DC50 of 0.03 nM. Giredestrant promotes the degradation of ERα protein, including the ESR1 Y537S mutant ERα. Giredestrant reduces uterine wet weight in immature rats and induces a low cuboidal phenotype in their endometrial epithelium. Giredestrant induces tumor regression in both ESR1 Y537S mutant and wild-type ERα tumor models. Giredestrant can be used for the research of ER + breast cancer .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-133017
CAS No.: 2114339-57-8
Purity:  99.79%
Synonyms: SAR439859
Target:  

Estrogen Receptor/ERR

Research Areas:  

Cancer

SAR439859 (compound 43d) is an orally active, non-steroidal, and selective estrogen receptor degrader (SERD). SAR439859 is an effective ER antagonist with ER degradation activity, an EC50 of 0.2 nM. SAR439859 can show potent anti-tumor effects and limited cross-resistance in ER + breast cancer.
loading...
    loading...